PACS Group (NYSE:PACS) Given New $64.00 Price Target at Royal Bank Of Canada

PACS Group (NYSE:PACS – Get Free Report) had its price target upped by equities research analysts at Royal Bank Of Canada from $57.00 to $64.00 in a research report issued on Monday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada‘s target price points to a potential upside of 30.85% from the company’s current price.

Several other research analysts have also weighed in on the stock. Truist Financial reissued a “buy” rating and set a $65.00 price objective (up from $62.00) on shares of PACS Group in a research note on Thursday, November 5th. Oppenheimer upped their target price on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Zacks Research lowered shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Stephens lifted their price target on shares of PACS Group from $60.00 to $64.00 and gave the stock an “overweight” rating in a research report on Thursday, November 5th. Finally, Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, PACS Group has a consensus rating of “Moderate Buy” and an average price target of $62.50.

View Our Latest Stock Analysis on PACS

PACS Group Trading Up 1.2%

NYSE:PACS traded up $0.59 during mid-day trading on Monday, hitting $48.91. The company had a trading volume of 55,705 shares, compared to its average volume of 891,898. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.80 and a current ratio of 0.80. PACS Group has a fifty-two week low of $12.71 and a fifty-two week high of $51.68. The firm has a market cap of $7.76 billion, a P/E ratio of 27.82, a P/E/G ratio of 1.57 and a beta of -0.14. The business’s fifty day moving average is $45.25 and its two-hundred day moving average is $40.38.

PACS Group (NYSE:PACS – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. As a group, research analysts expect that PACS Group will post 2.05 earnings per share for the current year.

Insider Activity

In related news, Director Mark Hancock sold 186,696 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the transaction, the director directly owned 53,318,884 shares in the company, valued at approximately $2,689,937,697.80. The trade was a 0.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16. Following the completion of the transaction, the chief executive officer owned 53,954,101 shares of the company’s stock, valued at $2,710,654,034.24. This represents a 0.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,697,064 shares of company stock worth $78,104,889 in the last quarter. 70.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in PACS. Cantor Fitzgerald Investment Advisors L.P. acquired a new position in PACS Group in the 3rd quarter worth $1,920,000. Squarepoint Ops LLC increased its holdings in PACS Group by 94.7% during the 2nd quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock worth $2,538,000 after purchasing an additional 28,945 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in PACS Group during the 2nd quarter worth about $1,893,000. Engineers Gate Manager LP acquired a new stake in shares of PACS Group in the 2nd quarter valued at about $1,132,000. Finally, Smith Group Asset Management LLC acquired a new stake in shares of PACS Group in the 1st quarter valued at about $771,000.

About PACS Group

(Get Free Report)

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.

Featured Articles

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.